^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

miR-141 expression

i
Other names: mir-141, MicroRNA 141, Hsa-MiR-141-3p, Hsa-MiR-141-5p, Hsa-Mir-141, MIRN141, MIR14
Entrez ID:
11ms
MALAT1 promotes epithelial-mesenchymal transition of pancreatic cancer cells through the miR-141-5p-TGF-ß-TGFBR1/TGFBR2 axis. (PubMed, Eur Cytokine Netw)
Furthermore, in PANC-1 cells, miR-141-5p overexpression suppressed TGF-induced epithelial-mesenchymal transition (EMT), cell migration, and cell invasion through direct binding to the 3'UTR of TGFBR1 and TGFBR2. Our results indicate that, in PC cells, miR-141-5p suppresses TGFBR1 and TGFBR2 expression and further inhibits TGF-β-induced EMT, cell migration, and cell invasion, which are reversed by overexpression of MALAT1, demonstrating that MALAT1 and miR-141-5p may be important regulators in the initiation and metastasis of PC.
Journal
|
MALAT1 (Metastasis associated lung adenocarcinoma transcript 1) • TGFBR2 (Transforming Growth Factor Beta Receptor 2) • TGFB1 (Transforming Growth Factor Beta 1) • MIR141 (MicroRNA 141) • TGFBR1 (Transforming Growth Factor Beta Receptor 1)
|
miR-141 expression
12ms
miR-141-3p inhibited BPA-induced proliferation and migration of lung cancer cells through PTGER4. (PubMed, Cytotechnology)
In conclusion, miR-141-3p can inhibit the proliferation and migration of BPA-induced lung cancer cells by downregulating PTGER4, providing a new potential target for the treatment and prevention of lung cancer. The online version contains supplementary material available at 10.1007/s10616-024-00692-5.
Journal
|
MIR141 (MicroRNA 141) • PTGER4 (Prostaglandin E Receptor 4)
|
miR-141 expression
1year
miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas. (PubMed, Sci Rep)
Members of the miR-200 family exhibit prognostic value for 2- and 5-year OS. Presented predictive models of survival may be clinically useful for treatment optimization.
Journal
|
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • MIR200B (MicroRNA 200b) • MIR200C (MicroRNA 200c) • MIR429 (MicroRNA 429) • MIR200A (MicroRNA 200a) • MIR141 (MicroRNA 141) • MIR200 (MicroRNA 200)
|
miR-200-a expression • miR-141 expression • miR-200-c expression • miR-429 expression
1year
miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. (PubMed, J Cancer)
Inhibition of miR-141-3p promoted Keap1 expression, inhibited Nrf2 and its downstream SLC7A11-GSH-GPX4 signaling pathway, as well as promoted ferroptosis in cancer cells, and inhibited paclitaxel and RSL3 resistance. In vivo, miR-141-3p mimics promoted paclitaxel resistance, whereas miR-141-3p inhibitors inhibited paclitaxel resistance in breast cancer cells. This work revealed that modulation of the Keap1-Nrf2 signaling pathway by miR-141-3p promoted paclitaxel resistance via regulating ferroptosis in breast cancer cells.
Journal
|
NFE2L2 (Nuclear Factor, Erythroid 2 Like 2) • GPX4 (Glutathione Peroxidase 4) • SLC7A11 (Solute Carrier Family 7 Member 11) • MIR141 (MicroRNA 141)
|
KEAP1 expression • miR-141 expression
|
paclitaxel • RSL3
over1year
HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis. (PubMed, Cell Death Dis)
Taken together, we discovered that SP1-induced HIF1A-AS2 can promote the metabolic reprogramming and progression of CRC via miR-141-3p/FOXC1 axis. HIF1A-AS2 is a promising diagnostic marker and treatment target in CRC.
Journal
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • FOXC1 (Forkhead Box C1) • MIR141 (MicroRNA 141)
|
HIF1A expression • FOXC1 expression • miR-141 expression
over1year
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells. (PubMed, BMC Cancer)
Together, these data uncover an efficient miR-141-based mechanism that supports cervical cancer progression and identifies miR-141 as a credible therapeutic target.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • TGFB1 (Transforming Growth Factor Beta 1) • MIR141 (MicroRNA 141) • KLRC1 (Killer Cell Lectin Like Receptor C1)
|
miR-141 expression
over1year
MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer. (PubMed, Int J Mol Sci)
High expression of miR-1206, miR-10a-5p, miR-141-3p, and miR-96-5p correlated with poor prognosis in OC patients according to the KM plotter database. These nine miRNAs could be used as targets for therapy and as markers of cisplatin response.
Preclinical • Journal
|
PTEN (Phosphatase and tensin homolog) • MIR200C (MicroRNA 200c) • MIR96 (MicroRNA 96) • MIR141 (MicroRNA 141) • MIR182 (MicroRNA 182) • SNAI2 (Snail Family Transcriptional Repressor 2) • ZEB1 (Zinc Finger E-box Binding Homeobox 1) • MIR183 (MicroRNA 183) • MIR203A (MicroRNA 203a)
|
ZEB1 expression • miR-141 expression
|
cisplatin
almost2years
microRNA-141-3p Suppressed the Progression of the Clear Cell Renal Cell Carcinoma by Targeting Transforming Growth Factor Beta 2 Gene Expression. (PubMed, DNA Cell Biol)
Furthermore, TGFβ2 overexpression abrogated the above changes regulated by miR-141-3p mimics. Taken together, miR-141-3p inhibited TGFβ1-induced EMT by suppressing the migration and invasion of ccRCC cells via directly targeting TGFβ2 gene expression.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • TGFB1 (Transforming Growth Factor Beta 1) • CDH2 (Cadherin 2) • MIR141 (MicroRNA 141) • TGFB2 (Transforming Growth Factor Beta 2)
|
CDH1 expression • VIM expression • miR-141 expression
almost2years
In silico investigation of the role of miRNAs in a possible developmental origin of prostate cancer in F1 and F2 offspring of mothers exposed to a phthalate mixture. (PubMed, Environ Toxicol)
Western blots showed alteration in P63, P53, WNT5, and STAT3 expression, which are targeted by the miRNAs, in the VP of F1/F2 males. The data draw attention to the epigenetic modulation in the prostate of descendants exposed to phthalates and adds to one of the few currently found in the literature to point to microRNAs signature as biomarkers of exposure to plasticizers.
Journal
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • TP63 (Tumor protein 63) • MIR141 (MicroRNA 141) • MIR184 (MicroRNA 184)
|
STAT3 expression • miR-141 expression
almost2years
Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression. (PubMed, J Cardiothorac Surg)
ATP2B1-AS1 sponge miR-141-3p alleviated the progression of LUAD, and ATP2B1-AS1 may be deemed as a prognostic marker for LUAD.
Journal
|
MIR141 (MicroRNA 141) • ATP2B1-AS1 (ATP2B1 Antisense RNA 1)
|
miR-141 expression
almost2years
Pattern of expression of microRNA in patients with radiation induced bladder injury. (PubMed, Oncology)
BC patients with fibrotic radiation injury have specific miRNA expression profile targeting pro-fibrotic cytokines and these miRNAs possibly renders to favorable survival.
Journal
|
MIR200C (MicroRNA 200c) • MIR96 (MicroRNA 96) • MIR141 (MicroRNA 141) • MIR130A (MicroRNA 130a)
|
miR-141 expression • miR-200-c expression
2years
Role of LncMALAT1-miR-141-3p/200a-3p-NRXN1 Axis in the Impairment of Learning and Memory Capacity in ADHD. (PubMed, Physiol Res)
All data verified our hypothesis that MALAT1 regulated synapse-related proteins (SYN1, PSD95, and GAP43) through the MALAT1-miR-141-3p/200a-3p-NRXN1 axis in ADHD. Our research underscored a novel role of MALAT1 in the pathogenesis of impaired learning and memory capacity in ADHD and may shed more light on developing diagnostic biomarkers and more effective therapeutic interventions for individuals with ADHD.
Journal
|
MALAT1 (Metastasis associated lung adenocarcinoma transcript 1) • MIR200A (MicroRNA 200a) • MIR141 (MicroRNA 141) • DLG4 (Discs Large MAGUK Scaffold Protein 4) • MIR200 (MicroRNA 200)
|
miR-141 expression